Catalyst Wire Dossier Catalyst Wire Dossier

Besifovir

besifovir · IlDong Pharmaceutical Co Ltd
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Besifovir, covering 2016-01-13 to 2023-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues [Phase 3]

See pricing